Somatostatin analogues therapy in gastroenteropancreatic neuroendocrine tumours: current aspects and new perspectives

Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are rare tumours that present many clinical features secreting peptides and neuroamines that cause distinct clinical syndromes such as carcinoid syndrome. However most of them are clinically silent until late presentation with mass effects. Su...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Author:	Roberto eBaldelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-02-01
Subjects:	Neuroendocrine Tumors Octreotide carcinoid somatostatin analogs lanreotide
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00007/full